Diclofenac-SOLOpharm

Application area

• Inhibition of miosis during cataract surgery (the medicine does not have mydriatic properties and does not replace the standard ones);
• Treatment and prevention of inflammatory processes after surgery on the eyeball;
• Prevention of cystic macular oedema after cataract surgery;
• Treatment of non-infectious conjunctivitis;
• Treatment and prevention of post-traumatic inflammatory process in penetrating and non-penetrating eyeball injuries (as an adjunct to local antibacterial therapy)